NEW YORK (GenomeWeb) – AusDiagnostics, an Australia-based multiplexed molecular diagnostics maker, announced today it has expanded its European footprint through partnering with four new distributors.
The new partnerships are with Medipro in Germany, BioProducts in Austria, EMM Life Science in Sweden, and ELIPS Ltd in Turkey.
AusDiagnostics uses a proprietary technology called Multiplexed Tandem PCR (MT-PCR), that enables multiplexing. As previously reported, the firm currently makes 28 in vitro diagnostic products to detect a combined 100 pathogens and also has plans to expand its presence in the US market.
According to a statement, AusDiagnostics also anticipates further growth in the European marketplace this year.